Predictive factors for the outcome of emotional and/or behavioural disorders in 18- to 48-month-old children after parent-child psychotherapy: Protocol of a European prospective cohort study.

Alliance thérapeutique Devenir Facteurs prédictifs Outcome Parent-child psychotherapy Predictive factors Psychothérapie parent-enfant Therapeutic alliance Toddlers disorders Troubles du jeune enfant

Journal

L'Encephale
ISSN: 0013-7006
Titre abrégé: Encephale
Pays: France
ID NLM: 7505643

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 26 04 2021
revised: 09 10 2021
accepted: 19 10 2021
medline: 22 5 2023
pubmed: 12 1 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

Several studies have shown that in young children, behavioural and/or emotional disorders are more difficult to manage than regulatory disorders. Moreover, data are lacking on outcome predictive factors. This article presents a short synthesis of previous research about outcome predictive factors in child psychiatry. It also describes the protocol of a longitudinal observational European multicentre study the main objective of which was to identify predictive factors of behavioural and emotional disorder outcome in toddlers after parent-child psychotherapy. The secondary objectives were to study predictive factors of the outcome in parents (anxiety/depression symptoms) and parent-child relationship. In order to highlight medium-effect size, 255 toddlers (age: 18 to 48 months) needed to be included. Outcomes will be assessed by comparing the pre- and post-therapy scores of a battery of questionnaires that assess the child's symptoms, the parents' anxiety/depression, and the parent-child relationship. Multivariate linear regression analysis will be used to identify predictive factors of the outcome among the studied variables (child age and sex, socio-economic status, life events, disorder type, intensity and duration, social support, parents' psychopathology, parents' attachment, parent-child relationships, therapy length and frequency, father's involvement in the therapy, and therapeutic alliance). This study should allow identifying some of the factors that contribute to the outcome of externalizing and internalizing disorders, and distinguishing between pre-existing and treatment-related variables. It should also help to identify children at higher risk of poor outcome who require special vigilance on the part of the therapist. It should confirm the importance of therapeutic alliance. ID-RCB 2008-A01088-47.

Identifiants

pubmed: 35012897
pii: S0013-7006(21)00261-X
doi: 10.1016/j.encep.2021.10.003
pii:
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-260

Informations de copyright

Copyright © 2021 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M-J Hervé (MJ)

Department of Child and Adolescent Psychiatry, CHRU Montpellier, St Eloi University Hospital, 80, avenue Augustin Fliche, 34295 Montpellier, France. Electronic address: mj-herve@chu-montpellier.fr.

V Maurice (V)

Department of Child and Adolescent Psychiatry, CHRU Montpellier, St Eloi University Hospital, 80, avenue Augustin Fliche, 34295 Montpellier, France.

L Gamon (L)

Clinical research and epidemiology unit (Department of Medicale Information), CHRU Montpellier, Univ Montpellier, Montpellier, France.

S Rusconi Serpa (S)

Department of Child and Adolescent Psychiatry, University of Geneva Hospitals, Genève, Switzerland.

D Trojan (D)

Department of Child and Adolescent Psychiatry, University of Geneva Hospitals, Genève, Switzerland.

N Guedeney (N)

DU de l'attachement, Université de Paris, Paris, France.

S Tereno (S)

Paris University, Laboratory of Psychopathology and Health Processes, Boulogne Billancourt, France.

A Guedeney (A)

Department of Child and Adolescent Psychiatry, Paris University-AP-HP, Paris, France.

M Myquel (M)

Department of Child and Adolescent Psychiatry, CoBTeK UCA team, Fondation Lenval - University Hospital, Nice, France.

A Fernandez (A)

Department of Child and Adolescent Psychiatry, CoBTeK UCA team, Fondation Lenval - University Hospital, Nice, France.

J-P Raynaud (JP)

University Department of Child and Adolescent Psychiatry, Inserm UMR 1295, CHU Toulouse, Purpan Hospital Toulouse, France.

F Poinso (F)

Department of Child and Adolescent Psychiatry, Ste Marguerite University Hospital, Aix-Marseille-University (AMU), Marseille, France.

M Maury (M)

Department of Child and Adolescent Psychiatry, CHRU Montpellier, St Eloi University Hospital, 80, avenue Augustin Fliche, 34295 Montpellier, France.

D Purper-Ouakil (D)

Department of Child and Adolescent Psychiatry, CHRU Montpellier, St Eloi University Hospital, 80, avenue Augustin Fliche, 34295 Montpellier, France.

M-C Picot (MC)

Clinical research and epidemiology unit (Department of Medicale Information), CHRU Montpellier, Univ Montpellier, Montpellier, France; Centre de Recherche en Épidémiologie et Santé des Populations (CESP), U1018, INSERM, Univ Paris-Saclay, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH